Naya Biosciences, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
INVO Fertility Director Matthew K Szot reported selling 4 shares and surrendering 3 shares of common stock, while holding adjusted stock options.
INVO Fertility, Inc. CEO Steve Shum was granted 42,000 stock options with an exercise price of $1.01, vesting over four quarters starting October 2025.
INVO Fertility, Inc. Director Matthew K Szot reported the acquisition of 45,000 stock options and beneficial ownership of common stock.
INVO Fertility, Inc. Director Barbara Ryan was granted 45,000 stock options and acquired 46 shares of common stock.
INVO Fertility's Chief Financial Officer, Andrea Goren, was granted 50,000 stock options with a $1.01 exercise price, vesting over four quarters.
INVO Fertility, Inc. Director Trent D. Davis acquired 45,000 stock options and disposed of 49 common shares, as reported in a recent SEC Form 4 filing.
INVO Fertility, Inc. Director Rebecca Messina was granted 45,000 stock options with an exercise price of $1.01, vesting quarterly.